Recently, Ganapathy et al. showed loss of expression of miR-299 in prostate tumors, and restored expression of this miRNA improved drug sensitivity and exhibited a tumor suppressor function that is mediated through targeting AR and vascular endothelial growth factor (VEGF)A [18]. This evidence concerns the gene VEGFA and prostate neoplasm.